Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.1.208EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.208ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.1.208ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.1.208EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.1.208EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.1.208ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.208ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.197EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.1.197EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.197ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.1.197ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.1.197EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.1.197EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.1.197ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.197ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.491EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.491EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.491ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.491ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.491EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.491EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.491ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.491ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BF.7.13.2ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
BF.7.13.2ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
BF.7.13.2EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
BF.7.13.2EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
BF.7.13.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BF.7.13.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BF.37EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BF.37EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BF.37ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
BF.37ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
BF.37EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
BF.37EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
BF.37ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BF.37ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
CK.3EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
CK.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
CK.3ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
CK.3ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
CK.3EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
CK.3EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
CK.3ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
CK.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
CM.5EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
CM.5EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
CM.5ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
CM.5ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
CM.5EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used